Human Molecular Genetics, 2000, Vol. 9, No. 17 2523-2530
© 2000 Oxford University Press
Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae
1Departments of Pediatric and Adolescent Medicine and Biochemistry and Molecular Biology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA, 2Division of Biochemistry and Genetics, Istituto Nazionale Neurologico ‘Carlo Besta’, Milan, Italy and 3Departments of Neurology and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
Frataxin is a nuclear-encoded mitochondrial protein widely conserved among eukaryotes. Human frataxin (fxn) is severely reduced in Friedreich ataxia (FRDA), a frequent autosomal recessive neuro- and cardio-degenerative disease. Whereas the function of fxn is unknown, the yeast frataxin homolog (Yfh1p) has been shown to be involved in mitochondrial iron homeostasis and protection from free radical toxicity. Evidence of iron accumulation and oxidative damage in cardiac tissue from FRDA patients suggests that fxn may have a similar function, but whether yeast and human frataxin actually have interchangeable roles in mitochondrial iron homeostasis is unknown. We show that a wild-type FRDA cDNA can complement Yfh1p-deficient yeast (yfh1
) by preventing the mitochondrial iron accumulation and oxidative damage associated with loss of Yfh1p. We analyze the functional effects of two FRDA point mutations, G130V and W173G, associated with a mild and a severe clinical presentation, respectively. The G130V mutation affects protein stability and results in low levels of mature (m) fxn, which are nevertheless sufficient to rescue yfh1 yeast. The W173G mutation affects protein processing and stability and results in severe m-fxn deficiency. Expression of the FRDA (W173G) cDNA in yfh1 yeast leads to increased levels of mitochondrial iron which are not as elevated as in Yfh1p-deficient cells but are above the threshold for oxidative damage of mitochondrial DNA and iron–sulfur centers, causing a typical yfh1 phenotype. These results demonstrate that fxn functions like Yfh1p, providing experimental support to the hypothesis that FRDA is a disorder of mitochondrial iron homeostasis.
+ To whom correspondence should be addressed. Tel: +1 507 266 0110; Fax: +1 507 284 1399; Email: isaya@mayo.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Pandolfo Friedreich Ataxia Arch Neurol, October 1, 2008; 65(10): 1296 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Boddaert, K. H. Le Quan Sang, A. Rotig, A. Leroy-Willig, S. Gallet, F. Brunelle, D. Sidi, J.-C. Thalabard, A. Munnich, and Z. I. Cabantchik Selective iron chelation in Friedreich ataxia: biologic and clinical implications Blood, July 1, 2007; 110(1): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Irazusta, E. Cabiscol, G. Reverter-Branchat, J. Ros, and J. Tamarit Manganese Is the Link between Frataxin and Iron-Sulfur Deficiency in the Yeast Model of Friedreich Ataxia J. Biol. Chem., May 5, 2006; 281(18): 12227 - 12232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Acquaviva, I. De Biase, L. Nezi, G. Ruggiero, F. Tatangelo, C. Pisano, A. Monticelli, C. Garbi, A. M. Acquaviva, and S. Cocozza Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2 J. Cell Sci., September 1, 2005; 118(17): 3917 - 3924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Campanella, G. Isaya, H. A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast Hum. Mol. Genet., October 1, 2004; 13(19): 2279 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-L. Bulteau, H. A. O'Neill, M. C. Kennedy, M. Ikeda-Saito, G. Isaya, and L. I. Szweda Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity Science, July 9, 2004; 305(5681): 242 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Karthikeyan, J. H. Santos, M. A. Graziewicz, W. C. Copeland, G. Isaya, B. V. Houten, and M. A. Resnick Reduction in frataxin causes progressive accumulation of mitochondrial damage Hum. Mol. Genet., December 15, 2003; 12(24): 3331 - 3342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Jauslin, T. Wirth, T. Meier, and F. Schoumacher A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy Hum. Mol. Genet., November 15, 2002; 11(24): 3055 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Park, O. Gakh, S. M. Mooney, and G. Isaya The Ferroxidase Activity of Yeast Frataxin J. Biol. Chem., October 4, 2002; 277(41): 38589 - 38595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Karthikeyan, L. K. Lewis, and M. A. Resnick The mitochondrial protein frataxin prevents nuclear damage Hum. Mol. Genet., May 16, 2002; 11(11): 1351 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cavadini, H. A. O'Neill, O. Benada, and G. Isaya Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia Hum. Mol. Genet., February 1, 2002; 11(3): 217 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tan, L.-S. Chen, B. Lonnerdal, C. Gellera, F. A. Taroni, and G. A. Cortopassi Frataxin expression rescues mitochondrial dysfunctions in FRDA cells Hum. Mol. Genet., September 1, 2001; 10(19): 2099 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Gordon, M. Kogan, S. A.B. Knight, A. Dancis, and D. Pain Distinct roles for two N-terminal cleaved domains in mitochondrial import of the yeast frataxin homolog, Yfh1p Hum. Mol. Genet., February 1, 2001; 10(3): 259 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cavadini, J. Adamec, F. Taroni, O. Gakh, and G. Isaya Two-step Processing of Human Frataxin by Mitochondrial Processing Peptidase. PRECURSOR AND INTERMEDIATE FORMS ARE CLEAVED AT DIFFERENT RATES J. Biol. Chem., December 22, 2000; 275(52): 41469 - 41475. [Abstract] [Full Text] [PDF]
|
|